This page is part of the FHIR Specification v6.0.0-ballot3: Release 6 Ballot (3rd Draft) (see Ballot Notes ). The current version is 5.0.0 . For a full list Continuous Integration Build of available versions, see FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

• Content
• Examples Detailed Descriptions
• Detailed Descriptions Search Params
• Mappings
• Operations Examples
• Search Params Operations
• Profiles
• Extensions

15.5.7 Resource AdministrableProductDefinition - Mappings

Maturity Level : N/A

Responsible Owner: Biomedical Research and Regulation Work Group

Standards Status : Informative

Security Category : Anonymous

Compartments : No defined compartments

Mappings for the AdministrableProductDefinition resource (see Mappings to Other Standards for further information & status).

15.5.7.1 FiveWs Pattern Mapping ( http://hl7.org/fhir/fivews )

AdministrableProductDefinition	administrative.medication
identifier	FiveWs.class

15.5.7.2 IDMP Mapping ( https://www.iso.org/obp/ui/#iso:std:iso:11615 )

AdministrableProductDefinition	Pharmaceutical Product
identifier	PhPID n/a
status	n/a
formOf	(link to Medicinal Product)
administrableDoseForm	Pharmaceutical Product.Administrable Dose Form
unitOfPresentation	Pharmaceutical Product.Unit of Presentation
producedFrom	n/a (this is the link from Pharmaceutical Product to the Manufactured Item(s))
ingredient	Pharmaceutical Product.Ingredient (see also FHIR Ingredient resource)
device	Pharmaceutical Product.Device
description	n/a
code	PhPID
property	Pharmaceutical Product Characteristics
type	Pharmaceutical Product Characteristics.Code System (not a one to one map, the resource is more capable)
value[x]	Pharmaceutical Product Characteristics.Value (not a one to one map, the resource is more capable)
status	Pharmaceutical Product Characteristics.Status
routeOfAdministration	Pharmaceutical Product.Route of Administration
code	Route of Administration.Route of Administration
firstDose	Dosing and Route of Administration.First dose in humans (Investigational Medicinal Product)
maxSingleDose	Dosing and Route of Administration.Maximum single dose (Investigational Medicinal Product)
maxDosePerDay	Dosing and Route of Administration.Maximum dose per day (Investigational Medicinal Product)
maxDosePerTreatmentPeriod	Dosing and Route of Administration.Maximum dose per treatment period (Investigational Medicinal Product)
maxTreatmentPeriod	Dosing and Route of Administration.Maximum treatment period (Investigational Medicinal Product)
targetSpecies	n/a
code	n/a
withdrawalPeriod	n/a
tissue	n/a
value	n/a
supportingInformation	n/a